Wegovy Pill Cost: Price With & Without Insurance (2026)

The Wegovy pill — once-daily oral semaglutide 25 mg, FDA-approved for weight management in December 2025 — is the newest way to get obesity-dose semaglutide without a needle. And the first question almost everyone asks is the same one: what does it cost? This guide lays out the oral Wegovy pill's pricing specifically — list price, what you'd pay with and without insurance, whether savings cards apply, and how the tablet stacks up against the injection on cost. Because it is a brand-new product, prices are still settling, so everything below is dated as of June 2026 — treat the numbers as ranges to verify with a pharmacy or the manufacturer, not fixed quotes.

One framing up front: the oral Wegovy pill is a prescription-only medicine, approved as an adjunct to diet and activity for chronic weight management¹. Nothing here is medical or financial advice — it is a map of the cost landscape so you can have a sharper conversation with a prescriber and your insurer. For what the pill actually is and what its trial showed, start with our explainer, the oral Wegovy pill (25 mg); this page is purely about the money.

The list price of the oral Wegovy pill

Like the injection, the oral Wegovy pill carries a high published list price — the manufacturer's wholesale figure before any insurance or discount. Novo Nordisk set the pill's monthly list price in the same general neighborhood as injectable Wegovy, roughly $1,300–$1,350 for a 28-day supply as of its launch. That is deliberate: the company priced the tablet at rough parity with the pen rather than as a budget alternative, because it delivers obesity-dose semaglutide with its own dedicated trial behind it².

As with the injection, though, the list price is the number the fewest people actually pay. It functions mainly as the ceiling that every discount below is measured against. What you pay depends almost entirely on your insurance status — and, importantly, on whether your plan covers the oral version at all, since it is new enough that some formularies have not yet added it.

Wegovy pill cost *with* insurance

If you have commercial (employer or marketplace) insurance that covers the oral Wegovy pill for weight loss, your out-of-pocket cost is a copay, not the list price — and the manufacturer's savings card can drive that copay down further. Novo Nordisk has run a savings offer for its Wegovy products that, for eligible commercially-insured patients, brings the monthly cost down to a small copay (the company has advertised figures as low as roughly $0 in the best cases, commonly in the tens of dollars), subject to monthly and annual caps on what the card pays.

Two honest caveats specific to the new pill:

• •Coverage of the oral version is not guaranteed. Because the pill launched in late 2025, some plans cover injectable Wegovy but have not yet added the oral form to their formulary, or place it on a higher tier. A savings card lowers your copay; it cannot create coverage your plan does not offer. We map the prior-authorization and exclusion maze in does insurance cover Wegovy or Ozempic?.
• •Government insurance is excluded from the savings card. If you are on Medicare, Medicaid, TRICARE, or any federal/state plan, you are not eligible for the manufacturer savings card — a legal restriction, not a technicality. And Medicare Part D is barred by statute from covering drugs used for weight loss, which applies to the oral pill exactly as it does to the injection.

Wegovy pill cost *without* insurance

This is where the new product's pricing gets interesting, and where it may diverge most from the injection. For cash payers, Novo Nordisk has run a self-pay program through NovoCare that sells brand-name Wegovy directly to people paying out of pocket, well below list price. That channel is now live for both formats and its prices are published rather than quoted: as of August 2026 the manufacturer's own mail-order pharmacy lists the injectable pens at $199/month for a new patient's first two fills and $349/month after that ($399/month for the 7.2 mg high-dose pen), and the oral tablet at $149/month for the 1.5 mg and 4 mg doses — with Novo's own footnote moving 4 mg to $199/month after 31 August 2026. Those are cash prices with no membership or consult fee attached, but also with no prescriber attached: NovoCare only dispenses.

Because the oral pill is so new, the exact cash figure is the single most fluid number in this guide — confirm the current NovoCare self-pay price for the oral form directly before you budget around it. What stays true regardless of the exact dollar amount:

• •It is for cash payers, generally meaning you are not running it through insurance.
• •It is real, FDA-approved, brand-name oral semaglutide — the same 25 mg tablet studied in the OASIS-4 trial, which showed about 16.6% average weight loss on treatment versus roughly 2.7% on placebo over 64 weeks³.
• •A genuine convenience win over the injection's cash route: the pill is a swallowed tablet, so there is no weekly injection to give yourself at all — and, as of August 2026, it is also the cheaper of the two on NovoCare's own price list.

If you would rather have the prescriber and the pharmacy in one place, Sesame Care carries the pill on a marketplace where you pick your own clinician and bills a platform subscription on top of the medication. For the broader cash-pay landscape on the injection — GoodRx coupons, the savings card, and the compounded-semaglutide grey market — see our companion Wegovy cost & savings guide.

Do GoodRx and coupons work on the Wegovy pill?

Expect the same recalibration that applies to the injection. GoodRx-type discount cards work best on generic or older drugs, where competition has pushed prices down. The oral Wegovy pill is a brand-new, single-source brand drug with no generic, so coupon prices are likely to land near or only slightly below list — not the dramatic cuts these cards deliver on, say, generic metformin. Use a discount card to comparison-shop pharmacy cash prices, but for the oral pill specifically, the manufacturer's direct self-pay route will almost certainly beat a GoodRx coupon. You generally cannot combine a manufacturer savings card with a GoodRx coupon on the same fill, so pick the cheaper single route.

One more caution unique to a brand-new product: be skeptical of any site advertising a cheap "oral semaglutide" or "semaglutide pill" for a fraction of these prices. There is no compounded version of the 25 mg oral Wegovy pill — what compounders such as Curex actually sell under an "oral" label is a dissolving tablet of compounded semaglutide, a different product at a different dose that has never been through OASIS-4 — and a low-priced "semaglutide tablet" is far more likely to be the diabetes-dose Rybelsus (capped at 14 mg, not approved for weight loss) or an unapproved grey-market product — not the obesity-dose pill at all. We explain that distinction in oral vs injectable semaglutide and Rybelsus.

Oral pill vs injection: which costs more?

On list price, the two are roughly the same — Novo priced the oral pill at rough parity with injectable Wegovy, not as a cheaper option². So the honest answer to "is the pill cheaper than the shot?" is: not on the sticker, and probably not by much on most routes either. The cost differences that do exist are mostly about format and convenience rather than a big price gap:

• •List price: roughly equal (~$1,300–$1,350/month for both as of June 2026).
• •With commercial insurance + savings card: similar copay logic for both, if your plan covers the oral form — which not all do yet.
• •Cash self-pay: the pill is the cheaper of the two here — NovoCare lists the oral tablet at $149/month for 1.5 mg and 4 mg against $199/month for a new patient's first two injection fills and $349/month after that. Novo's own footnote moves the 4 mg oral dose to $199/month after 31 August 2026.
• •Convenience trade-off: the pill avoids injecting entirely but demands a strict empty-stomach morning routine, while the injection is once weekly with no food-timing rules.

If your decision is really about cost and convenience rather than price alone, our full oral vs injectable semaglutide comparison weighs the daily-tablet routine against the weekly shot. The efficacy question matters too: the injection has the larger, longer evidence base, while the pill's 16.6% OASIS-4 result is newer and from a smaller trial³.

Why is the Wegovy pill priced where it is?

It is reasonable to wonder why a pill — usually the cheaper format in medicine — costs about the same as an injection here. A few honest reasons:

• •It is obesity-dose semaglutide with its own trial. The 25 mg oral pill is not a low-dose generic; it carries a dedicated FDA weight-management indication earned through the OASIS-4 program¹³, and the manufacturer prices it accordingly.
• •Oral semaglutide is hard to make. The stomach destroys peptides, so the tablet relies on an absorption enhancer and a far larger dose than the injection to get a small, variable fraction of drug into the bloodstream — manufacturing complexity that does not make the pill cheap to produce.
• •No competition yet. As the first and only oral GLP-1 approved for obesity², it has no direct branded rival and no generic, so there is little market pressure pushing the price down — for now.

How to pay less for the oral Wegovy pill

There is no single "cheapest" — it depends on your insurance status as of June 2026 — but the practical playbook is:

• •Check whether your plan covers the oral form specifically. Don't assume that coverage of injectable Wegovy carries over; ask member services, "Is the oral Wegovy 25 mg pill on my formulary, and what are the prior-authorization criteria?"
• •If covered commercially, use the manufacturer savings card for the lowest copay (often tens of dollars).
• •If uninsured or weight-loss-excluded, price the manufacturer's direct self-pay route for the oral form rather than paying list at a retail pharmacy.
• •Budget for the long run. Semaglutide manages weight rather than curing it, and weight tends to return when it is stopped — so this is typically ongoing therapy, not a one-month purchase. We cover that in what happens if you stop semaglutide?.
• •Compare legitimate providers on price and oversight before committing.

The honest bottom line

The oral Wegovy pill is priced at rough parity with the injection — a list price around $1,300–$1,350 a month as of June 2026 — so it is a convenience option, not a budget one. With commercial coverage, the manufacturer savings card usually wins; without insurance, the manufacturer's direct self-pay route is the legitimate cash path (confirm the current oral-form price, which is still settling); and GoodRx-type coupons rarely beat those on a brand-new brand drug. Watch for coverage gaps, since not every plan that covers the injection has added the pill yet — and be wary of suspiciously cheap "semaglutide pills," which are usually the diabetes-dose Rybelsus or an unapproved product, not the obesity-dose pill. Verify any number before you commit, and run the decision past a prescriber. For where to actually start, our independent best semaglutide providers guide ranks legitimate options on price and oversight, and our pillar Semaglutide: How It Works, Results & Side Effects covers what the drug does once you are on it.